Transient Eosinophilic Granulomatosis with Polyangiitis-Like Vasculitis During Omalizumab Therapy: A Case Report.
ANCA
Churg-Strauss syndrome
EGPA
anti-IgE antibodies
eosinophilia
vasculitis
Journal
Open access rheumatology : research and reviews
ISSN: 1179-156X
Titre abrégé: Open Access Rheumatol
Pays: New Zealand
ID NLM: 101688698
Informations de publication
Date de publication:
2020
2020
Historique:
received:
01
05
2020
accepted:
30
06
2020
entrez:
9
8
2020
pubmed:
9
8
2020
medline:
9
8
2020
Statut:
epublish
Résumé
A 67-year-old Caucasian female presented in August 2019 to our rheumatology service, with 3 days history of severe neck pain and right-sided headache with aches in both shoulders and arms and mild stiffness. Other symptoms included mild jaw claudication. She had recently returned from Majorca after an uneventful two-week trip. She had a background of severe allergic asthma and allergic rhinitis, well controlled with omalizumab which was started in 2016, based on persistently high IgE. Her sister suffers from a type of vasculitis and is currently on steroids. The patient is an ex-smoker and drinks two bottles of wine a week. She had high inflammatory markers with raised eosinophilic count and was admitted for further work up to rule out infection and to commence steroid after for a likely diagnosis of eosinophilic granulomatosis with polyangiitis. Shortly after admission to the acute assessment unit, she became confused and febrile. An extensive work up ruled out infection, and she was started on steroids and treated for acute hyponatremia. Omalizumab was stopped. She improved and was discharged on a tapering dose of steroids and was weaned off completely within 4 months. Her inflammatory markers returned to normal as well as her eosinophilic count, with complete resolution of her presenting symptoms.
Identifiants
pubmed: 32765129
doi: 10.2147/OARRR.S259746
pii: 259746
pmc: PMC7369362
doi:
Types de publication
Case Reports
Langues
eng
Pagination
127-131Informations de copyright
© 2020 Elhadari and Hamad.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest in this work.
Références
Arthritis Rheum. 1990 Aug;33(8):1094-100
pubmed: 2202307
J Radiol. 2009 Nov;90(11 Pt 1):1737-9
pubmed: 19953062
Int Arch Allergy Immunol. 2007;144(2):155-8
pubmed: 17536214
Arthritis Rheum. 2013 Jan;65(1):1-11
pubmed: 23045170
N Engl J Med. 2006 Sep 21;355(12):1281-2
pubmed: 16990394
Ann Allergy Asthma Immunol. 2017 Mar;118(3):372-374.e1
pubmed: 28094120
Chest. 2009 Aug;136(2):507-518
pubmed: 19411292
Eur J Rheumatol. 2015 Sep;2(3):129-130
pubmed: 27708948
World Allergy Organ J. 2018 Dec 3;11(1):39
pubmed: 30524647
J Allergy Clin Immunol. 2008 Jan;121(1):253-4
pubmed: 18206510
Int Arch Allergy Immunol. 2008;145(3):268
pubmed: 17921677